AR098198A1 - Antídotos anticoagulantes - Google Patents
Antídotos anticoagulantesInfo
- Publication number
- AR098198A1 AR098198A1 ARP140104022A ARP140104022A AR098198A1 AR 098198 A1 AR098198 A1 AR 098198A1 AR P140104022 A ARP140104022 A AR P140104022A AR P140104022 A ARP140104022 A AR P140104022A AR 098198 A1 AR098198 A1 AR 098198A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- antidotes
- anticoagulant
- cdr1
- cdr2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
Moléculas de anticuerpo contra anticoagulantes, en particular dabigatran, y su uso como antídotos de tales anticoagulantes. Reivindicación 1: Una molécula de anticuerpo contra dabigatran caracterizado porque comprende un dominio variable de la cadena pesada con una CDR1 de la SEQ ID Nº 1, una CDR2 de la SEQ ID Nº 2, y una CDR3 de la SEQ ID Nº 4, y un dominio variable de la cadena liviana con una CDR1 de la SEQ ID Nº 5, una CDR2 de la SEQ ID Nº 6, y una CDR3 de la SEQ ID Nº 7.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361895443P | 2013-10-25 | 2013-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR098198A1 true AR098198A1 (es) | 2016-05-18 |
Family
ID=51795624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140104022A AR098198A1 (es) | 2013-10-25 | 2014-10-24 | Antídotos anticoagulantes |
Country Status (7)
Country | Link |
---|---|
US (1) | US9499633B2 (es) |
EP (1) | EP3060583A1 (es) |
JP (1) | JP2016539926A (es) |
AR (1) | AR098198A1 (es) |
TW (1) | TW201609816A (es) |
UY (1) | UY35795A (es) |
WO (1) | WO2015059159A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6887613B2 (ja) * | 2016-03-31 | 2021-06-16 | 国立大学法人東北大学 | がん微小環境を標的とした抗ポドカリキシン抗体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI513466B (zh) * | 2010-01-20 | 2015-12-21 | Boehringer Ingelheim Int | 抗凝血劑解毒劑 |
WO2012130834A1 (en) * | 2011-03-30 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Anticoagulant antidotes |
-
2014
- 2014-10-21 JP JP2016525867A patent/JP2016539926A/ja active Pending
- 2014-10-21 WO PCT/EP2014/072579 patent/WO2015059159A1/en active Application Filing
- 2014-10-21 EP EP14789547.8A patent/EP3060583A1/en not_active Withdrawn
- 2014-10-23 US US14/521,499 patent/US9499633B2/en active Active
- 2014-10-24 UY UY0001035795A patent/UY35795A/es unknown
- 2014-10-24 TW TW103136872A patent/TW201609816A/zh unknown
- 2014-10-24 AR ARP140104022A patent/AR098198A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW201609816A (zh) | 2016-03-16 |
EP3060583A1 (en) | 2016-08-31 |
US20150118225A1 (en) | 2015-04-30 |
UY35795A (es) | 2015-04-30 |
WO2015059159A1 (en) | 2015-04-30 |
JP2016539926A (ja) | 2016-12-22 |
US9499633B2 (en) | 2016-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591750A1 (ru) | Антитела против b7-h4 и иммуноконъюгаты | |
CL2017000545A1 (es) | Anticuerpos anti-her2 e inmunoconjugados | |
EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
CR20150048A (es) | Anticuerpos e inmunoconjugados anti-cd22 | |
EA201790834A1 (ru) | Молекулы антител к pd-l1 и их применение | |
CR20160425A (es) | Moléculas de anticuerpos que se unen a lag-3 y usos de las mismas | |
CO7151529A2 (es) | Anticuerpos anti-cd22 e inmunoconjugados | |
EA201691488A1 (ru) | Молекулы антител против pd-1 и их применения | |
CO7151527A2 (es) | Anticuerpos anti-cd79 b e inmunoconjugados | |
EA201691556A1 (ru) | Молекулы антител к tim-3 и их применение | |
EA201790569A1 (ru) | Антитела и иммуноконъюгаты против cll-1 | |
MX2015017331A (es) | Anticuerpos anti fc similar a receptor 5 (fcrh5). | |
EA201691991A1 (ru) | Мультиспецифические антитела | |
WO2014144865A3 (en) | Anti-crth2 antibodies and their use | |
TN2012000366A1 (en) | Anticoagulant antidotes | |
AR085758A1 (es) | Antidotos anticoagulantes | |
WO2013177055A3 (en) | ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | |
EA201590993A1 (ru) | Гетеродимерные иммуноглобулины | |
EA201390933A1 (ru) | Антитела против мезотелина и иммуноконъюгаты | |
NZ761537A (en) | Anti-human ox40l antibodies, uses & methods | |
MX2019015604A (es) | Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia. | |
WO2015010100A3 (en) | Humanized antibodies with ultralong complementarity determining regions | |
EP3561057A4 (en) | ANTI-CD3 ANTIBODY AND MOLECULE CONTAINING LEDIT ANTIBODY | |
WO2015017146A3 (en) | Antibodies with ultralong complementarity determining regions | |
EA201792055A1 (ru) | Антитела против cd48 и их конъюгаты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |